Glaucoma (Eye Disease) and its Associated Diagnosis and Treatment Process: A Schematic Concise Review

Yash Srivastav *

Azad Institute of Pharmacy & Research, Lucknow, U.P, India.

Bushra Taj

Ashoka Institute of Technology and Management, Varanasi, U.P, India.

Jaya Singh

Tahira Institute of Medical Science, Gorakhpur, U.P, India.

Sandhya Yadav

Tahira Institute of Medical Science, Gorakhpur, U.P, India.

Mohd. Imtiyaz Ahmad

Azad Institute of Pharmacy & Research, Lucknow, U.P, India.

*Author to whom correspondence should be addressed.


A class of eye conditions known as glaucoma can result in blindness and visual loss by harming the optic nerve, a nerve located at the back of the eye. You might not notice the symptoms at first because they can appear so slowly. A thorough dilated eye exam is the only way to determine if you have glaucoma. While there is no known cure for glaucoma, vision protection and damage can frequently be stopped with early intervention. Primary open-angle and angle-closure glaucoma, as well as secondary open and angle-closure glaucoma, are the four main types of adult glaucoma. Prescription eye drops are the most popular form of treatment for glaucoma. They function by reducing intraocular pressure and shielding your optic nerve from harm. Although these eye drops cannot reverse vision loss or treat glaucoma, they can prevent glaucoma from worsening. Prostaglandins are one type of prescription eye drop medication. By increasing the fluid's outflow from your eye, they aid in lowering intraocular pressure. Latanoprost (Xalatan), Travoprost (Travatan Z), Tafluprost (Zioptan), Bimatoprost (Lumigan), and Latanoprostene bunod (Vyzulta) are among the medications in this category. Alpha-adrenergic agonists, such as brimonidine (Altagan P) or Qoliana (Iopidine, apraclonidine) Beta-blockers such as Betimol, Istalol, Timoptic (timolol), and Betoptic (betaxolol) Inhibitors of carbonic anhydrases, such as Azopt (brinzolamide) and Trusopt (dorzolamide). In this review study, we discuss the aetiology, epidemiology, current management, and pathophysiology of glaucoma.

Keywords: Glaucoma, epidemiology, etiology, pathophysiology, treatments

How to Cite

Srivastav, Y., Taj, B., Singh, J., Yadav, S., & Ahmad, M. I. (2024). Glaucoma (Eye Disease) and its Associated Diagnosis and Treatment Process: A Schematic Concise Review. Ophthalmology Research: An International Journal, 19(3), 42–50.


Download data is not yet available.


Grewe R. Zur Geschichte des Glaukoms [The history of glaucoma]. Klin Monbl Augenheilkd. 1986;188(2):167–9.

Leffler CT, Schwartz SG, Hadi TM, Salman A, Vasuki V. The early history of glaucoma: The glaucous eye (800 BC to 1050 AD). Clin Ophthalmol. 2015;9:207–15.

Schellack N. Glaucoma : A brief review. 2016;(January 2015).

Allison K, Patel D, Alabi O. Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future. Cureus. 2020;12(11).

Rewri P. Towards better management of glaucoma in India. Indian J Ophthalmol. 2023;71(3):686–8.

Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-jonas S. Seminar Glaucoma. 2017;390:83–93.

Bourne RRA, Stevens GA, White RA, Smith JL, Flaxman SR, Price H, et al. Causes of vision loss worldwide, 1990 – 2010 : A systematic analysis. 2012;339–49.

Khaw PT, Elkington AR. Glaucoma—1: Diagnosis. Bmj. 2004;328(7431):97.

George A, Yanan L, Dominic MKL. Normal tension glaucoma: Prevalence, aetiology and treatment. J Clin Res Ophthalmol. 2021;8:023–8.

Turalba A V., Chen TC. Clinical and genetic characteristics of primary juvenile-onset open-angle glaucoma (JOAG). Semin Ophthalmol. 2008;23(1):19–25.

Drance S, Anderson DR SM. Collaborative Normal-Tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 2001;131:699–708.

Sivak-Callcott JA, O’Day DM, Gass JDM, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. 2001;108(10):1767–76.

Muir MGK, Hitchings RA. Syndrome. 2015;

Kiuchi Y, Kanamoto T, Nakamura T. Double hump sign in indentation gonioscopy is correlated with the presence of plateau iris configuration regardless of patent iridotomy. J Glaucoma. 2009;18(2):161–4.

Izquierdo NJ, Traboulsi EI, Enger C, Maumenee IH, Walton DS, Ferry AP, et al. Glaucoma in the Marfan syndrome. Trans Am Ophthalmol Soc. 1992;90:111–22.

Perez RN, Phelps CD, Burton TC. Angel-closure glaucoma following scleral buckling operations. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976;81(2):247–52.

Aminlari A, East M, Wei W, Quillen D. Topiramate Induced Acute Angle Closure Glaucoma. Open Ophthalmol J. 2008; 2(1):46–7.

Calafiore S, Perdicchi A, Scuderi G, Contestabile MT, Abdolrahimzadeh S, Recupero SM. Glaucoma management in carotid cavernous fistula. Case Rep Ophthalmol. 2016;7(2):296–302.

Plateroti P, Plateroti AM, Abdolrahimzadeh S, Scuderi G. Pseudoexfoliation syndrome and pseudoexfoliation glaucoma: A review of the literature with updates on surgical management. J Ophthalmol. 2015 ;2015.

Posner A, Schlossman A. Further observations on the syndrome of glaucomatocyclitic crises. Trans - Am Acad Ophthalmol Otolaryngol Am Acad Ophthalmol Otolaryngol. 1953;57(4):531–6.

Roll P, Benedikt O. [Electronmicroscopic studies of the trabecular meshwork in corticosteroid glaucoma]. Klin Monbl Augenheilkd. 1979 Mar;174(3):421–8.

Choong YF, Irfan S, Menage MJ. Acute angle closure glaucoma: An evaluation of a protocol for acute treatment. Eye. 1999;13(5):613–6.

Piplani P, Aggarwal D, Abbhi V, Saini L. Prostaglandin analogues: A current treatment option for glaucoma. Med Chem Res. 2016;25(6):1031–48.

Arora T, Bali SJ, Arora V, Wadhwani M, Panda A, Dada T. Diurnal versus office-hour intraocular pressure fluctuation in primary adult-onset glaucoma. J Optom [Internet]. 2015;8(4): 239–43. Available:

Drance SM, Sweeney VP, Morgan RW, Feldman F. Factors involved in the production of low tension glaucoma. Can J Ophthalmol. 1974 Oct;9(4):399–403.

Levene RZ. Low tension glaucoma: A critical review and new material. Surv Ophthalmol. 1980;24(6):621–64.

Dietze J, Blair K, Havens SJ. Glaucoma. [Updated 2022 Jun 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available: 2024;538217.

Pasol J. Neuro-ophthalmic disease and optical coherence tomography: Glaucoma look-alikes. Curr Opin Ophthalmol. 2011; 22(2):124–32.

Greenfield DS. Glaucomatous versus nonglaucomatous optic disc cupping: Clinical differentiation. Semin Ophthalmol. 1999;14(2):95–108.

Kehinde LE, Montes R, Moreno SC. Subconjunctival hemorrhage. Clin Cases Eye Care. 2018;269–71.

Lusthaus J, Goldberg I. Current management of glaucoma. Med J Aust. 2019;210(4):180–7.

Wright C, Tawfik MA, Waisbourd M, Katz LJ. Primary angle-closure glaucoma: an update. Acta Ophthalmol. 2016 May; 94(3):217–25.

Bai HQ, Yao L, Wang DB, Jin R, Wang YX. Causes and treatments of traumatic secondary glaucoma. Eur J Ophthalmol. 2009;19(2):201–6.

Anderson DR. Collaborative normal tension glaucoma study. Curr Opin Ophthalmol. 2003 Apr;14(2):86–90.

Craven ER, Katz LJ, Wells JM, Giamporcaro JE. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: Two-year follow-up. J Cataract Refract Surg [Internet]. 2012;38(8):1339–45. Available: